Biodesix is a leader in developing and commercializing non-invasive, blood-based diagnostic tests for oncology, used by treating physicians, clinical research institutions, and biopharma partners. Our mission is to develop and provide innovative tests that change medical practice and improve the lives of patients.

Unlike most cancer diagnostics, our tests require only a simple blood draw (versus a tissue sample) and results are available within 72 hours – the fastest turnaround time on the market. Our commercially available tests utilize a multi-omic approach to lung cancer diagnostics to help physicians make faster, more informed treatment decisions based on their patient’s mutation profile and their immune response to their cancer. New tests in development focus on answering additional clinical questions for physicians, earlier in the lung cancer continuum of care, including risk of cancer recurrence post-resection, and likelihood of benefit from immunotherapy treatment.

Biodesix also collaborates with leading researchers and builds strategic partnerships with biotechnology and pharmaceutical companies to develop companion diagnostics and build our pipeline of new products. We explore biological pathways to help achieve a more complete understanding of the body’s response to cancer.  Biodesix can provide reliable, reproducible tests utilizing our proprietary machine learning platform to classify patients into groups based on specific clinical outcomes.

Biodesix research and development activities are conducted with the highest clinical integrity, including external validation with medical experts and properly designed and controlled clinical trials. Our internal controls are designed to ensure compliance with applicable federal, state, and local statutes and regulations relevant to providers of healthcare services.

Biodesix is located in Boulder, Colorado; our tests are all performed onsite in our best-in-class diagnostic laboratory, certified by CAP, CLIA, CLEP and ISO 13485. Only 1% of medical laboratories receive all of these certifications.